Rocket Pharmaceuticals (RCKT) Earnings Analysis

Rocket Pharmaceuticals (RCKT) next reports earnings on 2026-08-06, consensus EPS 1.04 USD. Last quarter (2026-05-07) it missed with EPS -0.42 USD vs -0.41 USD est (-2.4%). It has beaten estimates in 6/8 recent quarters (75%). Trailing P/E -1.76.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does RCKT next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate1.04 USD
Revenue estimate0.00B

RCKT earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-07-0.42 USD-0.41 USD-2.4%Miss
2026-02-26-0.38 USD-0.42 USD+9.5%Beat
2025-11-06-0.45 USD-0.48 USD+6.2%Beat
2025-08-07-0.59 USD-0.57 USD-3.5%Miss
2025-05-08-0.56 USD-0.59 USD+5.1%Beat
2025-02-27-0.62 USD-0.68 USD+8.8%Beat
2024-11-07-0.71 USD-0.78 USD+9%Beat
2024-08-05-0.74 USD-0.74 USD0%Beat

Beat rate: 6/8 (75%) over reported quarters with consensus data.

RCKT valuation and analyst view

Trailing P/E-1.76
Trailing EPS-1.86726 USD
Price / book1.55
Dividend yield0.00%
Market cap0.37B
Analyst consensusBuy (13 buy / 4 hold / 2 sell)
Avg price target6 USD

Related research pages

Frequently asked questions

When is Rocket Pharmaceuticals (RCKT)'s next earnings date?

Rocket Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 1.04 USD and revenue estimate of 0.00B.

Did RCKT beat earnings last quarter?

In its 2026-05-07 report, RCKT posted EPS of -0.42 USD versus a -0.41 USD estimate — a miss of 2.4%.

What is RCKT's earnings track record?

Over the last 8 reported quarters with consensus data, RCKT beat estimates 6 times (75%).

What is RCKT's current P/E ratio and EPS?

RCKT trades at a trailing P/E of -1.76 on trailing EPS of -1.8672560492972077 USD.

What do analysts rate RCKT?

Analyst consensus is "Buy" across 19 ratings (0 strong buy, 13 buy, 4 hold, 2 sell, 0 strong sell). Average 12-month price target: 6 USD.